The World Health Organization (WHO) today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with TB in 2023 – the highest number recorded ...
One of the main challenges of contemporary medicine is posed by the resistance of pathogens to antibiotics. An important step in countering it has now been made by researchers from IOCB Prague, in ...
The National Institutes of Health has identified several CYP3A4 inducers, including "barbiturates (phenobarbital), carbamazepine, corticosteroids, phenytoin, rifampicin and St John's wort." ...
tuberculosis complex that is resistant to rifampicin and isoniazid. The treatment success rate for people diagnosed with MDR/RR-TB has steadily improved but remains alarmingly low. Nwokafor and others ...